China Is Raising Government Support For Biotech Industry In Next Five-year Plan
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - While China's National Development and Reform Commission is drafting its 12th five-year plan, government officials and its think tank recently disclosed that the biotech industry will be raised as a pillar industry and China is increasing its support to facilitate development of the industry
You may also be interested in...
China's Government Investment, Policies Sustain IVD Market With High Double-digit Growth
SHANGHAI - China's in vitro diagnostics market was valued at $2 billion in 2009 and is expected to keep a steady pace of 18.5 percent compound annual growth rate in the next three to five years, according to global consulting company Frost & Sullivan
China's Government Investment, Policies Sustain IVD Market With High Double-digit Growth
SHANGHAI - China's in vitro diagnostics market was valued at $2 billion in 2009 and is expected to keep a steady pace of 18.5 percent compound annual growth rate in the next three to five years, according to global consulting company Frost & Sullivan
Biopharma Industry Slated As China Pillar Industry, But Key Domestic Support Missing
SHANGHAI - Biopharmaceuticals will take a share in the Chinese central government's RMB 62.8 billion ($9.18 billion) investment plan to facilitate 11 key projects during 2009 to 2010. China's State Council passed a policy in May to promote the biotech industry to develop it as one of China's pillar industries in the future